Last 23,950 KRW
Change Today +150.00 / 0.63%
Volume 4.0
As of 2:07 AM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

lg life sciences ltd (068875) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/24/14 - 25,400
52 Week Low
04/25/14 - 20,000
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LG LIFE SCIENCES LTD (068875)

Related News

No related news articles were found.

lg life sciences ltd (068875) Related Businessweek News

No Related Businessweek News Found

lg life sciences ltd (068875) Details

LG Life Sciences Co, Ltd. researches, develops, produces, and sells pharmaceuticals, animal health products, and specialty chemicals in South Korea and internationally. Its pharmaceutical products include Eutravac and Euforvac vaccines for diphtheria, tetanus, acellular and whole cell pertussis, and r-DNA hepatitis B; Follitrope, a follicle stimulating hormone; Euvax B vaccine against infection caused by various subtypes of hepatitis B virus; LG influenza HA vaccine against influenza virus type A and type B; and LG DTaP vaccine for diphtheria, tetanus, and aceulluar Pertussis infection. The company also provides Espogen, a drug for anemia in patients with chronic renal failure; cardiovascular drugs, such as Xilep XL, Novamet GR, Zanidip, Acecol, Calvan, LG Enalapril, and LG Cilastasol; Eutropin, an endocrine drug; and anti-infective drugs, including Factive, Intermax-Alpha, Cefatame, LG Ceftriaxone, Tarocef, and Ribavirin. In addition, it offers Hyruan and Hyruan Plus for the osteoarthritis of knees and shoulder periarthritis; Hyal 2000 and Hyal Plus that are used during surgical procedures on the eyes; YVOIRE for the correction of facial wrinkles and folds; and Protescal for the reduction of post-surgical adhesion. Its oncology drugs consist of Intermax Gamma, LG Megestrol, and LG Tumercide; and infertility drugs include Follitrope, IVF-M, IVF-C, and Follimon; and specialty chemicals consist of crop protection products, such as insecticides, fungicides, herbicides, and pest management products, as well as active pharmaceutical intermediates. The company’s animal health products consist of Boostin-S and Boostin-250, which are milk production stimulants; and diagnostics products comprise ELISA kits; Real-time PCR kits; GenoBlot kits; and allergy screening system. LG Life Sciences, Ltd. is headquartered in Seoul, South Korea.

lg life sciences ltd (068875) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lg life sciences ltd (068875) Key Developments

LG Life Sciences, Ltd. and Mochida Pharmaceutical Co. Ltd. Sign Agreement for Treatment of Autoimmune Disease

LG Life Sciences Ltd. and Mochida Pharmaceutical Co. Ltd, have signed agreement for Humira Biosimilar, a treatment for the autoimmune disease, in Japan market. Mochida will have exclusive right for developing and sales of Humira Biosimilar in Japan which is currently in clinical study by LG Life Sciences. After commercialization, LG Life Sciences will supply drug product to Mochida.

Lupin Limited Announces Strategic Distribution Agreement with LG Life Sciences

Lupin Limited announced a strategic distribution agreement with LG Life Sciences to launch Insulin Glargine, a novel insulin analogue under the brand name Basugine. According to the agreement, Lupin would be responsible for marketing and sales of Basugine in India.

LG Life Sciences, Ltd., Annual General Meeting, Mar 14, 2014

LG Life Sciences, Ltd., Annual General Meeting, Mar 14, 2014., at 10:30 Korea Standard Time. Location: Jongno-newspaper 2 LG Gwanghwamun, the base of the building, second floor auditorium. Agenda: To consider the 12th (2013) financial statements (statement of retained earnings (not)), and approval of the consolidated financial statements; to consider some change in constitution; tpo consider the election of directors; to appoint Audit Committee; and to consider the approval of director remuneration.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
068875:KS 23,950.00 KRW +150.00

068875 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 068875.
View Industry Companies

Industry Analysis


Industry Average

Valuation 068875 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LG LIFE SCIENCES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at